Ilika plc (LON: IKA), an independent global expert in solid-state battery technology, has announced that it has appointed Cavendish Capital Markets Limited as Nominated Adviser and Sole Broker with immediate effect.
Ilika appoints Cavendish Capital Markets as Nominated Adviser and Sole Broker
- Written by: Amilia Stone
Find more news, interviews, share price & company profile here for:
Latest Company News
Ilika CEO Graeme Purdy discusses Stereax product revenue, planned M300 battery deliveries, Goliath 10Ah development, EV market trends and rising demand from the defence sector.
Dr Tom McColm of Morphose Capital Partners explains why the company may be approaching an important commercial inflection point.
Ilika plc CEO Graeme Purdy outlines how Stereax has started generating product-related revenue, why M300 battery deliveries remain on track and how Goliath’s 10Ah prototype is opening new opportunities in defence and sovereign battery supply.
Ilika Plc reports annual results for the year ended 30 April 2026, highlighting progress on its Stereax medical battery line and Goliath large-format batteries for EV, defence and consumer applications. The company began Stereax production and deliveries, shipped larger Goliath prototypes, secured further grant funding and raised £5 million post-period to accelerate commercialisation.
Defence applications are increasing the need for specialist batteries that can deliver reliable power in demanding operating conditions.
Battery & Energy Storage Tech Europe 2026 will focus on financing, deployment, manufacturing, recycling and regulation across Europe’s battery market.
